Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.96
Delayed Data
As of Sep 22
 -0.01 / -0.03%
Today’s Change
29.83
Today|||52-Week Range
36.21
+10.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line1.3B866.0M3.1B3.1B
 
 
 
 
 
Depreciation1.4B1.5B1.6B1.6B
 
 
 
 
 
Total Other Cash Flow1.7B1.1B-907.0M-56.0M
 
 
 
 
 
Funds From Operations3.1B4.2B3.8B4.9B
 
 
 
 
 
Funds From/For Other Operating Expenses-1.6B-1.8B2.2B1.6B
 
 
 
 
 
Net Cash Flow - Operating Activities4.7B6.0B1.6B3.3B
 
 
 
 
 
 
InvestingIncrease In Investments-7.8B-8.2B-1.4B-2.6B
 
 
 
 
 
Decrease In Investments16.9B6.6B6.9B1.6B
 
 
 
 
 
Capital Expenditures-432.0M-689.0M-358.0M-448.0M
 
 
 
 
 
Net Assets From Acquisitions -13.1B-689.0M-585.0M-415.0M
 
 
 
 
 
Other Investing - Sources34.0M-8.0M297.0M158.0M
 
 
 
 
 
Net Cash Flow Investing-4.4B-3.1B4.8B-1.7B
 
 
 
 
 
 
FinancingShort Term Borrowings-85.0M-2.8B-2.1B2.0B
 
 
 
 
 
Long Term Borrowings0.005.9B5.3B0.00
 
 
 
Long Term Debt Reduction0.00-3.4B-1.3B-3.2B
 
 
 
 
Net Proceeds Stock Sale250.0M73.0M313.0M98.0M
 
 
 
 
 
Common Preferred Redeemed0.000.00-5.0B0.00
 
 
Common Dividends----------
Cash Dividends Paid - Total-1.8B-1.8B-1.9B-1.9B
 
 
 
 
 
Other Sources - Financing----------
Other Uses - Financing----220.0M8.0M
 
 
 
Net Cash Flow - Financing-1.6B-2.2B-4.9B-3.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-11.0M-136.0M21.0M16.0M
 
 
 
 
 
 
Net Change In Cash-1.3B638.0M1.4B-1.5B